The civic record
Read. Follow. Verify.South Dakota authorizes pharmacists to dispense ivermectin and hydroxychloroquine under provider protocols with liability protections
Last action · February 5, 2026: Do Pass AmendedSponsors: Bobbi Andera and 21 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Pharmacists in South Dakota are newly authorized to dispense ivermectin and hydroxychloroquine to adults aged 18 or older without a traditional patient-specific prescription, provided they follow a written protocol established by a licensed health care provider. The measure also grants civil and criminal immunity, as well as protection from professional licensing boards, to pharmacists and health care providers acting in good faith under these protocols, barring or willful misconduct.
Adult residents gain direct access to specific medications through participating pharmacies via standardized health protocols, while participating health care providers and pharmacists are shielded from legal and professional liability except in cases of or willful misconduct.
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
Individuals 18 years or older
Adult residents gain the ability to obtain ivermectin or hydroxychloroquine directly from a pharmacist under a provider protocol.
Pharmacists
Pharmacists are authorized to dispense specific medications using non-patient-specific protocols and receive conditional liability protections.
Licensed health care providers
Providers are permitted to develop written protocols for dispensing these medications and receive conditional liability protections.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Who is eligible to receive ivermectin or hydroxychloroquine under these protocols?
Are pharmacists protected from liability when dispensing these drugs under a protocol?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in House committee.
Procedural history
5 actions- Feb 5, 2026HouseCommitteeDo Pass Amended
- Feb 3, 2026HouseCommitteeDo Pass Amended
- Feb 3, 2026HouseMotion to amend
- Feb 3, 2026HouseScheduled for hearing
- Jan 15, 2026HouseIntroducedFirst read in House and referred to
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Voting Record
Do Pass Amended
Total
70
- Yes
- 28
- No
- 40
- Present
- 0
- Not voting
- 0
- Abstain
- 0
- Other positions
- 2
How they voted (70)
46 more members
Show 1 earlier roll call
Do Pass Amended
Total
13
- Yes
- 8
- No
- 5
- Present
- 0
- Not voting
- 0
- Abstain
- 0
How they voted (13)
Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Show 17 more sponsors
Connected Entities
Sources
sdlegislature.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 65)
- Controversy75Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz50Current news / social attention level
Publisher tools
